Nice quote at the Winter Olympics Opening Ceremony: "Tradition is not the worship of ashes but the preservation of fire". I like that. #winterolympics

Will FemTech improve women’s healthcare – or make inequalities worse? This month's guest expert is Dr Andrea Ford, PhD, Wellcome Trust Research Fellow in Humanities and Social Sciences at The University of Edinburgh. Her work is funded by our Early Career Awards, part o...

FemTech is technology focused on women's health.

These apps can give useful health insights. But there are serious concerns about privacy.

Learn more from Dr Andrea Ford @edinburgh-uni.bsky.social ⤵️
www.linkedin.com/pulse/femtech-improve-wo...

Misinformation around paracetamol use in pregnancy When US President Donald Trump cautioned pregnant women against taking paracetamol (acetaminophen in the USA) during a September 2025 press briefing, claiming the drug increases the risk of autism in ...

News just published in @lancetobgyn-wh.bsky.social on misinformation surrounding #paracetamol use in #pregnancy.

Read it here: www.thelancet.com/journals/lan...

#obgynsky #womenshealth #medsky

Our third issue (November 2025) is now live!

❓Did you know that our first three issues, as well as a lot of current online content, are completely free to access? Take a look now!
🖱️ www.thelancet.com/journals/lan...

#medsky #obgynsky #womenshealthsky

Very proud of our October issue; it was my turn to write the Editorial, and I decided to write about World Contraception Day.

Cover of The Lancet Obstetrics, Gynaecology, & Women's Health. The illustration shows a woman and the outline of a woman: the woman holds a stethoscope to the woman's outline. Within the outline are 6 images of women in different stages of their life.

Our inaugural issue is out now! 🎉

Explore and download our first issue and read featured content, Editor's picks, announcements, and much more on our journal homepage: hubs.li/Q03GFPRK0

Thank you to our authors and reviewers!

#medsky #physician-researcher #obgynsky #womenshealthsky

The primary cilium and main cilia-mediated signalling pathways

I was so happy to see this Review on primary ciliopathies published Online First in The Lancet Neurology today! www.thelancet.com/journals/lan... I commissioned this Review after attending the BNA Festival of Neuroscience in 2023. It has been a long journey, but worth the wait. A beautiful Review!

Marte-Helene Bjørk on reproductive risks in people with epilepsy - The Lancet Neurology in conversation with Sarah Passey is joined by Dr Marte-Helene Bjørk (Haukeland University Hospital, Norway) to discuss the latest evidence and practical guidance on managing reproductive risks in people with epilepsy, in...

Our Deputy Editor, Sarah Passey (@soggous.bsky.social) recently hosted a podcast for our sister journal, The Lancet Neurology (@thelancetneuro.bsky.social). Sarah interviewed Marte-Helene Bjork about management of reproductive risk in people with epilepsy www.buzzsprout.com/1391383/epis...

Enjoying my time in Vienna at the @myesmo.bsky.social gynaecological cancers meeting. Learning a lot about the new trials and advances in care. Looking forward to meeting some delegates today. Please reach out if you’d like to meet.

Femtech and women's health - The Lancet Voice How safe is it to use period tracking and digital contraception apps? Who is your data being shared with? What regulation actually exists in this area to protect app users?Femtech offers women digital...

Femtech offers women digital tools for tracking reproductive health.

Dr. Catriona McMillan joins our editors to talk about how accurate these apps actually are, significant concerns about data privacy, and regulatory oversight.

🔊 Listen now: tinyurl.com/3dsdsku5

A really great video from @lancetobgyn-wh.bsky.social featuring @muliyilsonia.bsky.social talking about our new journal!
#womenshealth #obgyn

I'll be in Vienna next month at #ESMOGynae25 and I'm very happy to meet Lancet authors and reviewers to discuss ongoing research and how the Lancet group can help publish your work.

Join me and my colleagues on May 14th to discuss publishing with The Lancet Obstetrics, Gynaecology, & Women's Health. What are we looking for in a paper? What do authors need to provide? Register & more info 👉 hubs.li/Q03hCtQR0
#medsky #healthcare #womenshealth #obskyn #obgynsky #reprosky

Publishing excellence with The Lancet Obstetrics, Gynaecology, & Women's Health

On May 14th, join me and my colleagues at The Lancet Obstetrics, Gynaecology, & Women’s Health (@lancetobgyn-wh.bsky.social) for our webinar on publishing excellence! You can find out more and register here: hubs.li/Q03hCsjF0
#medsky #womenshealth

Of course they were. Apparently, only white men are allowed to be in charge again.

Withdrawal of the United States from the WHO — How President Trump Is Weakening Public Health | NEJM Severing the long-standing ties and scientific collaborations between the United States and the WHO and slashing U.S. financial support will have catastrophic effects on both domestic and global he...

A Perspective in The New England Journal of Medicine on President Trump's withdrawal of the USA from WHO in 2026. The consequences of this action are so worrying.
www.nejm.org/doi/full/10....

Just ran to LinkedIn to check 😂

Reducing postpartum haemorrhage Nearly 300 000 women die every year due to pregnancy or childbirth. Substantial inroads in reducing maternal mortality were made during the early part of the 21st century, but progress has stalled ove...

The latest Editorial from The Lancet (@thelancet.bsky.social) looks at initiatives to reduce the incidence of postpartum haemorrhage, including the new WHO campaign "Healthy beginnings, hopeful futures", which will prioritise women's health #hopefulfutures www.thelancet.com/journals/lan...

Thanks Ursula! The acronym is a challenge 😆

From next week, I will be joining The Lancet Obstetrics, Gynaecology, & Women's Health as the Deputy Editor. I am excited for this new challenge, although sad to be leaving The Lancet Neurology! Please reach out if you are doing any neurological research in the women's health field, I'd love to chat

RIP USAID — all remaining 900 employees will be fired.

A new hybrid journal at The Lancet, launching later this year! It is fantastic to finally see this journal among The Lancet portfolio.

I was delighted to interview Mike Tymianski from the University of Toronto for this month's podcast for The Lancet Neurology. We talked about neuroprotection for ischaemic stroke, and how novel therapies might one day be able to save brain tissue from damage. #stroke #neurosky

Crossing the blood–brain barrier: emerging therapeutic strategies for neurological disease The blood–brain barrier is a physiological barrier that can prevent both small and complex drugs from reaching the brain to exert a pharmacological effect. For treatment of neurological diseases, drug...

New Personal View online at The Lancet Neurology, looking at some emerging strategies to get drugs across the blood–brain barrier #neurology @thelancet.bsky.social This paper came about after I attended a talk at the Festival of Neuroscience in 2023 #neuroscience www.thelancet.com/journals/lan...

The Lancet Neurology Editors on advances in neurology in 2024 - The Lancet Neurology in conversation with The Lancet Neurology Editors take a look back at advances in neurology in 2024, as highlighted by experts in a series of Round-ups published in the January issue.

The latest episode of The Lancet Neurology's podcast is out, featuring the Editors (yes, including me!) talking about notable advances in neurology in 2024. Check it out! thelancetneurology.buzzsprout.com/1391383/epis...

Diagnosis and management of status epilepticus: improving the status quo Status epilepticus is a common neurological emergency that is characterised by prolonged or recurrent seizures without recovery between episodes and associated with substantial morbidity and mortality. Prompt recognition and targeted therapy can reduce the risk of complications and death associated with status epilepticus, thereby improving outcomes. The most recent International League Against Epilepsy definition considers two important timepoints in status epilepticus: first, when the seizure does not self-terminate; and second, when the seizure can have long-term consequences, including neuronal injury.

A very nice Review was recently published in The Lancet Neurology on status epilepticus, focused on advances in diagnosis and management. #criticalcare #epilepsy #neurology @thelancet.bsky.social www.thelancet.com/journals/lan...

@maogden.bsky.social Welcome to BlueSky!

Some interesting #stroke content published online by The Lancet Neurology (www.thelancet.com/journals/lan...), the PROST-2 RCT of recombinant human prourokinase vs alteplase, showing safety and efficacy, and an Insight discussing evidence for blood pressure lowering in stroke management

I have no idea what you mean! A super-sub-bleusque! (I went French but blousque ok too 😜)

The Lancet Neurology in conversation with Editors at The Lancet Neurology, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.A monthly audio companion to...

As a way of introducing myself, I thought you might like to hear me. I occasionally interview neurologists and neuroscientists for The Lancet Neurology In Conversation With podcast. You can listen to the podcast (and previous episodes) here: www.buzzsprout.com/1391383/epis... @thelancet.bsky.social